AngioDynamics Reports FQ211 Financial Results

AngioDynamics ANGO today reported financial results for the fiscal 2011 second quarter ended November 30, 2010. Net sales in the second quarter were $53.4 million, virtually identical to the $53.5 million reported in the prior year period. Oncology sales increased 16% to $15.9 million from the prior year, and included $1.6 million in NanoKnife System sales, up from $1.1 million in the fiscal 2011 first quarter. Vascular sales were $37.5 million, a decrease of 6% from the second quarter a year ago. Effective for the fiscal year beginning June 1, 2010, Vascular sales include both Peripheral Vascular and Access product lines, for which the Company combined the respective sales forces. International sales in the second quarter grew 12% to $6.7 million from the prior year period.